Scrip: industry news and insights
Updates and coverage of the 2020 J.P. Morgan Healthcare Conference in San Francisco.
The data and analysis for this webinar were drawn from Pink Sheet and Scrip, both part of the Informa Pharma Intelligence suite of intelligence solutions. More than just news, Pink Sheet delivers analysis, and commentary focused on regulatory implications, including high-value perspectives from insiders and thought leaders across the globe – giving regulatory professionals an objective view of how to anticipate challenges, minimize risks, and maximize opportunities for their business. Scrip boasts over 60 journalists and analysts dedicated to bringing you the latest news and insights with everything from licensing, clinical trials, and competitor activity. Hear directly from the newsmakers, leverage best-in-class proprietary data, and follow the latest market developments with a Scrip account.
Datamonitor Healthcare: data analysis and insight, Biomedtra...
As the biopharma industry concludes its annual pilgrimage to San Francisco for the JP Morgan investor conference, much of the talk around town inevitably was about gene therapies.
Topics Cell and gene therapy
Pink Sheet: global policy and regulatory coverage
An interactive timeline shows the news of the past decade and the evolution of US FDA policies. Click on each year for a full list of events and see the accompanying article.
Whether you’re a small biotech start-up, research firm, generic manufacturer or a global pharmaceutical giant, you need focused, independent insight and opinion on market developments.
Our team is always happy to hear from you. Please call us at:
Have an immediate and specific information need?
Browse and buy from 1000s of analysis and research reports now: